IGHE and Alzheimer disease: However, previous attempts to neutralize single mediators in AD have been rather disappointing, e.g. anti-IL-5 [49] and anti-IgE [50, 51], presumably due to the redundancy of disease-driving mediators combined with the heterogeneous nature of the disease.